Chemed Corporation provides hospice and palliative care services in the United States. It operates through two segments, VITAS and Roto-Rooter. The VITAS segment offers direct medical services, as well as spiritual and emotional counseling services to terminally ill patients. This segment offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and operated territories, independent contractor-operated territories, and franchised locations. This segment also manufactures and sells products and equipment, including drain cleaning machines and drain cleaning solutions. The company was founded in 1970 and is headquartered in Cincinnati, Ohio.
Industry, Sector and Symbol
Industry Home health care services
Sub-IndustryHealth Care Services
Trailing P/E Ratio60.39
Forward P/E Ratio29.53
Sales & Book Value
Annual Sales$1.67 billion
Price / Sales3.10
Cash Flow$7.9705 per share
Price / Cash40.61
Book Value$33.84 per share
Price / Book9.57
EPS (Most Recent Fiscal Year)$5.36
Net Income$98.17 million
Return on Equity33.05%
Return on Assets17.97%
Chemed (NYSE:CHE) Frequently Asked Questions
What is Chemed's stock symbol?
Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."
How often does Chemed pay dividends? What is the dividend yield for Chemed?
Chemed declared a quarterly dividend on Monday, May 21st. Investors of record on Thursday, May 31st will be given a dividend of $0.28 per share on Wednesday, June 20th. This represents a $1.12 annualized dividend and a yield of 0.35%. The ex-dividend date of this dividend is Wednesday, May 30th. View Chemed's Dividend History.
How will Chemed's stock buyback program work?
Chemed declared that its board has authorized a stock buyback program on Wednesday, March 7th 2018, which allows the company to buyback $150,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to reacquire shares of its stock through open market purchases. Shares buyback programs are generally a sign that the company's management believes its shares are undervalued.
How were Chemed's earnings last quarter?
Chemed Co. (NYSE:CHE) announced its earnings results on Thursday, April, 19th. The company reported $2.72 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.36 by $0.36. The company had revenue of $439.18 million for the quarter, compared to the consensus estimate of $419.33 million. Chemed had a return on equity of 33.05% and a net margin of 6.67%. Chemed's quarterly revenue was up 8.2% compared to the same quarter last year. During the same quarter last year, the business earned $1.82 EPS. View Chemed's Earnings History.
When is Chemed's next earnings date?
What guidance has Chemed issued on next quarter's earnings?
Chemed updated its FY18 earnings guidance on Thursday, April, 19th. The company provided EPS guidance of $10.60-10.85 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $10.72.
What price target have analysts set for CHE?
3 Wall Street analysts have issued 1 year price objectives for Chemed's stock. Their forecasts range from $258.00 to $275.00. On average, they expect Chemed's stock price to reach $266.50 in the next twelve months. View Analyst Ratings for Chemed.
Who are some of Chemed's key competitors?
Who are Chemed's key executives?
Chemed's management team includes the folowing people:
- Mr. Kevin J. McNamara, CEO, Pres & Director (Age 64)
- Mr. David P. Williams, Exec. VP & CFO (Age 57)
- Mr. Spencer S. Lee, Exec. VP (Age 62)
- Mr. Nicholas Michael Westfall, Exec. VP (Age 39)
- Mr. Timothy S. O'Toole, Consultant (Age 62)
Has Chemed been receiving favorable news coverage?
News articles about CHE stock have been trending somewhat positive on Sunday, Accern reports. The research group scores the sentiment of news coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Chemed earned a news impact score of 0.22 on Accern's scale. They also gave headlines about the company an impact score of 44.51 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the near term.
Who are Chemed's major shareholders?
Chemed's stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (13.45%), Neuberger Berman Group LLC (5.71%), Fisher Asset Management LLC (3.02%), Gamco Investors INC. ET AL (2.69%), Dimensional Fund Advisors LP (2.25%) and Van Berkom & Associates Inc. (2.17%). Company insiders that own Chemed stock include Arthur V Tucker Jr, David Patrick Williams, Donald E Saunders, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace and Spencer S Lee. View Institutional Ownership Trends for Chemed.
Which institutional investors are selling Chemed stock?
CHE stock was sold by a variety of institutional investors in the last quarter, including Gamco Investors INC. ET AL, Eaton Vance Management, Van Berkom & Associates Inc., UBS Group AG, Neuberger Berman Group LLC, Gabelli Funds LLC, WINTON GROUP Ltd and Eagle Boston Investment Management Inc.. Company insiders that have sold Chemed company stock in the last year include David Patrick Williams, Donald E Saunders, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace and Spencer S Lee. View Insider Buying and Selling for Chemed.
Which institutional investors are buying Chemed stock?
CHE stock was bought by a variety of institutional investors in the last quarter, including Summit Trail Advisors LLC, JPMorgan Chase & Co., Rockefeller Capital Management L.P., BlackRock Inc., Barclays PLC, Great Lakes Advisors LLC, Schwab Charles Investment Management Inc. and Copeland Capital Management LLC. Company insiders that have bought Chemed stock in the last two years include Donald E Saunders and George J Walsh III. View Insider Buying and Selling for Chemed.
How do I buy shares of Chemed?
Shares of CHE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Chemed's stock price today?
One share of CHE stock can currently be purchased for approximately $323.68.
How big of a company is Chemed?
Chemed has a market capitalization of $5.16 billion and generates $1.67 billion in revenue each year. The company earns $98.17 million in net income (profit) each year or $5.36 on an earnings per share basis. Chemed employs 14,813 workers across the globe.
How can I contact Chemed?
Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The company can be reached via phone at 513-762-6690.
MarketBeat Community Rating for Chemed (CHE)MarketBeat's community ratings are surveys of what our community members think about Chemed and other stocks. Vote "Outperform" if you believe CHE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CHE will underperform the S&P 500 over the long term. You may vote once every thirty days.